SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from Stealth BioTherapeutics Corp (CIK 0001696396) — Jun 13, 2022

Stealth BioTherapeutics Corp (CIK 0001696396)
Date: June 13, 2022 · CIK: 0001696396 · Accession: 0001564590-22-023057

AI Filing Summary & Sentiment

File numbers found in text: 333-265423

Date
June 13, 2022
Author
Not clearly detected
Form
CORRESP
Company
Stealth BioTherapeutics Corp (CIK 0001696396)

Letter

mito-corresp.htm

STEALTH BIOTHERAPEUTICS CORP

c/o Intertrust Corporate Services (Cayman) Limited

One Nexus Way

Camana Bay, Grand Cayman

KY1-9005 Cayman Islands

June 13, 2022

VIA EDGAR SUBMISSION

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Re:

Stealth BioTherapeutics Corp

Registration Statement on Form F-1

File No. 333-265423

Request for Acceleration

Ladies and Gentlemen:

Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Stealth BioTherapeutics Corp hereby requests acceleration of the effective date of its Registration Statement on Form F-1 (File No. 333-265423), so that it may become effective at 4:00 p.m., Eastern time, on June 15, 2022, or as soon as practicable thereafter.

Very truly yours,
STEALTH BIOTHERAPEUTICS CORP

Show Raw Text
CORRESP
1
filename1.htm

mito-corresp.htm

STEALTH BIOTHERAPEUTICS CORP

c/o Intertrust Corporate Services (Cayman) Limited

One Nexus Way

Camana Bay, Grand Cayman

KY1-9005 Cayman Islands

June 13, 2022

VIA EDGAR SUBMISSION

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Re:

Stealth BioTherapeutics Corp

Registration Statement on Form F-1

File No. 333-265423

Request for Acceleration

Ladies and Gentlemen:

Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Stealth BioTherapeutics Corp hereby requests acceleration of the effective date of its Registration Statement on Form F-1 (File No. 333-265423), so that it may become effective at 4:00 p.m., Eastern time, on June 15, 2022, or as soon as practicable thereafter.

Very truly yours,

STEALTH BIOTHERAPEUTICS CORP

By:

/s/ Irene P. McCarthy

Name:

Title:

Irene P. McCarthy

Chief Executive Officer